Why the study?
Heart failure diagnosis and management are challenging in elderly patients due to atypical presentations, requiring specialized multidisciplinary care and biomarker-assisted risk stratification.
This review highlights the challenges of diagnosing and managing heart failure in the elderly, emphasizing the role of biomarkers and holistic assessment.
Answers are grounded in this paper and cite their sources.
Challenges in elderly HF diagnosis and management require specialized multidisciplinary care; leaves open optimal biomarker strategies for atypical presentations.
Heart failure (HF) is a common condition and one of the main morbidity and mortality factors in elderly patients. The incidence of HF progressively increases with age, reaching to >10% in those aged 70 years or over. In the elderly population both the diagnosis and the management of HF prove challenging, often requiring specialized care and multidisciplinary approach. In seniors atypical presentation of HF is much more common than in younger patients, thus a holistic assessment with biomarkers related to HF allows for early diagnosis and accurate risk stratification in this group of patients. This article reviews the clinical and diagnostic differences in elderly patients with HF, highlighting the presence of comorbidities, frailty, cognitive impairment and polypharmacy, as well as discusses potential biomarkers that may have clinical application in this population.
No takes yet. Share an insight, caveat, or question.
Szczurek et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: